Prilocaine for Sphenopalatine Ganglion Block in Endoscopic Hypophysectomy
ConditionBlood Pressure Control
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-45
SponsorKasr El Aini Hospital
About this trial
Patients undergoing endoscopic surgeries for pituitary adenoma excision suffer from wide swings in blood pressure that might increase bleeding and interfere with the surgical field.
Local anethetic infiltration and regional nerve blocks have been used to provide better analgesia, control blood pressure and improve surgical field.
Limited studies evaluated shenopalatine ganglion block in pituitary adenoma excision with promising outcomes. The proposed study will compare the efficacy of two local anesthetics, prilocaine and lidocaine, for spenopalatine ganglion block in patients undergoing endoscopic pituitary adenoma excision. Evaluating the control of the intraoperative blood pressure and analgesic sparing are the main objectives of the proposed study.
Eligibility criteria
Qualifiers
Patients with pituitary adenoma undergoing endoscopic hypophysectomy.
ASA physical status I and II.
Age above 21, below 45 years.
Male or female
Disqualifiers
Any patient below 21 years or above 45 years.
Disturbed conscious level.
Coagulation abnormalities.
Poorly controlled blood pressure and/or heart rate.
Trial design
Treatments tested in this trial
- Sphenopalatine Ganglion Block using 2% lidocaine
- Sphenopalatine Ganglion Block
- Sphenopalatine Ganglion Block
Treatment groups
54 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov